Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study
原发肿瘤位置对接受一线化疗联合抗EGFR或抗VEGF单克隆抗体治疗的RAS野生型转移性结肠癌患者的影响:一项回顾性多中心研究
期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.34550
Grassadonia, Antonino; Di Marino, Pietro; Ficorella, Corrado; Cortellini, Alessio; Cannita, Katia; Parisi, Alessandro; Gamucci, Teresa; Zoratto, Federica; Vici, Patrizia; Barba, Maddalena; Porreca, Ettore; Neri, Matteo; Veronese, Angelo; Natoli, Clara; De Tursi, Michele; Tinari, Nicola
单克隆抗体
肿瘤
肠癌
肿瘤免疫
EGF
EGFR
RAS
VEGF